Mario Scuri

2.7k citations
53 papers · 1.9k · 3 hit papers · h-index 19

Impact in

    • Chronic Obstructive Pulmonary Disease (COPD) Research
    • Inhalation and Respiratory Drug Delivery
    • Respiratory Support and Mechanisms
    • Respiratory and Cough-Related Research
    • Neonatal Respiratory Health Research
  • Physiology top 2%
    • Asthma and respiratory diseases

Papers in

    • Chronic Obstructive Pulmonary Disease (COPD) Research 18
    • Inhalation and Respiratory Drug Delivery 17
    • Respiratory and Cough-Related Research 9
    • Respiratory Support and Mechanisms 4
    • Asthma and respiratory diseases 17

Mario Scuri

49 papers receiving 1.8k citations

Mario Scuri's Hit Papers

Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial 2018 · 411 citations
4110+3+6Years since publication100200300400

Peers

Mario Scuri
Comparison fields: 5 of 114
  • Pulmonary and Respiratory Medicine 1.2k
  • Physiology 698
  • Issues, ethics and legal aspects 26
  • Immunology 165
  • Genetics 75
Replace Dinesh K. Pillai with:
Dinesh K. Pillai United States
Jennifer Trevor United States
Simone Brandenburg Netherlands
Halina Batura‐Gabryel Poland
Carol A. Tozzi United States
Katsutoshi Nakayama Japan
Tsutomu Tamada Japan
Harold G. de Bruin Netherlands
Stephen T. Holgate United Kingdom
Yuan-jue Zhu China
Mario Scuri relative to Dinesh K. Pillai United States Dinesh K. Pillai's profile →
Citations per field
00.5×6.5×
Dinesh K. Pillai · 1×
Citations per year

Countries citing papers authored by Mario Scuri

Since Specialization
Citations

This map shows the geographic impact of Mario Scuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Scuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Scuri more than expected).

Fields of papers citing papers by Mario Scuri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Scuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Scuri. The network helps show where Mario Scuri may publish in the future.

Co-authors

The 25 scholars most cited alongside Mario Scuri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mario Scuri Line = papers co-authored together Mario Scuri links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
Hit paper breakdown →
2018411
2
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial
Hit paper breakdown →
2017293
3
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
Hit paper breakdown →
2016288
4 2000134
5 1996116
6 201067
7 199348
8 201347
9 200645
10 199544
11 200641
12 201038
13 200331
14 201730
15 200028
16 202125
17 201424
18 199721
19 200118
20 200215

About Mario Scuri

Mario Scuri is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Emergency Medical Services, Molecular Biology and Epidemiology, having authored 53 papers that have together received 1.9k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers), Inhalation and Respiratory Drug Delivery (17 papers), Asthma and respiratory diseases (17 papers), Respiratory and Cough-Related Research (9 papers), Pediatric health and respiratory diseases (5 papers), Respiratory Support and Mechanisms (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.2k citations), Physiology (698 citations), Issues, ethics and legal aspects (26 citations), Immunology (165 citations) and Genetics (75 citations). Mario Scuri has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Stefano Vezzoli, Dave Singh, Jørgen Vestbo, Alberto Papi, Massimo Corradi, Isabella Montagna, Géraldine Cohuet, William M. Abraham, Catherine Francisco and Stefano Petruzzelli. Their work appears in journals such as Journal of Applied Physiology, Pulmonary Pharmacology & Therapeutics, American Journal of Respiratory and Critical Care Medicine, The Lancet and BMC Pulmonary Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact